ie618 company profile presentation bayer schering (germany)caudill/bayer.pdf · arne stöcker denis...
TRANSCRIPT
Arne Stöcker
Denis Stoimenov Waldemar SeelJoachim Hacke Wan Mohd Norudin
IE618
Company Profile Presentation
Bayer Schering (Germany)
Arne Stoecker
02/16/2011
Source: www.bayerscheringpharma.de
Arne Stöcker
Denis Stoimenov Waldemar SeelJoachim Hacke Wan Mohd Norudin
Outline
1. Introduction and history
2. Financial summary
3. Scope of products
4. Cost and business issues
Arne Stöcker
Denis Stoimenov Waldemar SeelJoachim Hacke Wan Mohd Norudin
Name and corporate type
• Bayer Schering Pharma AG
• “Aktiengesellschaft“ = Corporation
– Since September 2008 not listed anymore
– Subsidiary of Bayer AG
• Pharmaceutical company
• Headquarter: Berlin, Germany
Introduction and History
Arne Stöcker
Denis Stoimenov Waldemar SeelJoachim Hacke Wan Mohd Norudin
Background
• 1851
– Ernst Schering purchased chemist´s shop
• 1863
– Friedrich Bayer establishes a dyestuff factory
• 1897
– Bayer develops the active ingredients of aspirin
Introduction and History
Arne Stöcker
Denis Stoimenov Waldemar SeelJoachim Hacke Wan Mohd Norudin
Background
• 2000
– Schering AG was listed on the NYC stock exchange
• 2002
– Bayer AG was listed on the NYC stock exchange
• 2003
– Bayer Healthcare is established as independent legal entity
• 2006
– Merger of Schering AG and Bayer AG
• 2007
– Bayer Schering operates as a division of Bayer Healthcare
subgroup
Introduction and History
Arne Stöcker
Denis Stoimenov Waldemar SeelJoachim Hacke Wan Mohd Norudin
StructureBayer AG
Subgroups
Bayer MaterialScience
Bayer CropScience
Bayer HealthCare
Bayer Schering Pharma AG
Animal Health
Consumer Care
Medical Care
Service companies
Bayer Business Services
Bayer Technology
Services
Currenta
39% of Bayer Health
Care Revenue
Source: www.bayerscheringpharma.de
Introduction and History
Arne Stöcker
Denis Stoimenov Waldemar SeelJoachim Hacke Wan Mohd Norudin
Structure
Bayer Schering
Pharma AG
Diagnostic Imaging
X-ray contrast media
Women´s Healthcare
Menopause management
Specialty Medicine
Drugs for solid tumor
therapy
Age related eye diseases
General Medicine
High blood pressure
Men´s Healthcare
Bacterial infection
Introduction and History
Arne Stöcker
Denis Stoimenov Waldemar SeelJoachim Hacke Wan Mohd Norudin
Locations
• Headquarter
– Berlin, Germany
• R&D
– Berlin, Wuppertal, Cologne, Leverkusen, Germany
– Berkley, CA, Montville, NJ, USA
– Osaka, Japan
– Peking, China
• Production
– Europe, USA, Asia
Introduction and History
Arne Stöcker
Denis Stoimenov Waldemar SeelJoachim Hacke Wan Mohd Norudin
Size (Capitalization, Employees)
• Employees
– > 36,000 world wide (Schering had 24,000)
• > 5,800 in R&D
• 100% Stockholder is the Bayer Schering GmbH
– A wholly owned subsidiary of the Bayer AG
• Bayer AG
– Business financing: 35% self
– Company value: ~ $60 billion
– Assets : ~ $24.7 billion
Introduction and History
Source: dutypharmacy.com
Arne Stöcker
Denis Stoimenov Waldemar SeelJoachim Hacke Wan Mohd Norudin
Top executives
Introduction and History
Arne Stöcker
Denis Stoimenov Waldemar SeelJoachim Hacke Wan Mohd Norudin
Partnerships
• Bausch & Lomb
– Selective receptor for treatment of eye diseases
• Johnson & Johnson
– Development of anticoagulant
• Pfizer
– Development of inhibitor for diabetes
Introduction and History
Arne Stöcker
Denis Stoimenov Waldemar SeelJoachim Hacke Wan Mohd Norudin
Outline
1. Introduction and history
2. Financial summary
3. Scope of products
4. Cost and business issues
Arne Stöcker
Denis Stoimenov Waldemar SeelJoachim Hacke Wan Mohd Norudin
Financial Report
• R&D expenditures ~$ 2,025 billion (2009)
Source: dpa
Financial Summary
2008 2009 Change
$ billion $ billion %
Revenue $13,541 $14,130 4.4%
EBIT $1,650 $2,290 38.8%
Arne Stöcker
Denis Stoimenov Waldemar SeelJoachim Hacke Wan Mohd Norudin
Stock trend (Bayer AG)
Financial Summary
Arne Stöcker
Denis Stoimenov Waldemar SeelJoachim Hacke Wan Mohd Norudin
Outline
1. Introduction and history
2. Financial summary
3. Scope of products
4. Cost and business issues
Arne Stöcker
Denis Stoimenov Waldemar SeelJoachim Hacke Wan Mohd Norudin
Products / Primary markets
Product Indication Business area Net sales(million)
Yasmin/ YAZ/ Yasminelle hormonal contraceptive Womes Healthcare $ 1,725
Betaferon/ Betaseron multiple sclerosis Specialty Medicine $ 1,639
Kogenate/ Helixate hemophilia Specialty Medicine $ 1,199
Adalat high blood pressure General Medicine $ 855
Nexavar kidney and liver cancer Specialty Medicine $ 815
Mirenahormonal intrauterine
delivery system for contraceptionWomes Healthcare $ 662
Avalox/ Avelox respiratory tract infections General Medicine $ 621
Levitradrug for treating erectile
dysfunctionGeneral Medicine $ 486
Cipro/ Ciprobay infectious diseases General Medicine $ 447
Glucobay Diabetes General Medicine $ 444
Scope of products
Arne Stöcker
Denis Stoimenov Waldemar SeelJoachim Hacke Wan Mohd Norudin
Competitors
• Pfizer
• Bristol-Myers Squibb
• Merck KGaA (EMD)
• Teva Pharmaceutical Industries Ltd.
Scope of products
Arne Stöcker
Denis Stoimenov Waldemar SeelJoachim Hacke Wan Mohd Norudin
Outline
1. Introduction and history
2. Financial summary
3. Scope of products
4. Cost and business issues
Arne Stöcker
Denis Stoimenov Waldemar SeelJoachim Hacke Wan Mohd Norudin
Current critical business issues
• 2000 - Death of seven teenagers in relation to “Yasmin”
• 2010 - Facing lawsuit in Germany because of pregnancy
test from 1970
• 2010 - Company announced to change the name to
Bayer HealthCare and drop the “Schering”
Cost and business issues
Arne Stöcker
Denis Stoimenov Waldemar SeelJoachim Hacke Wan Mohd Norudin
Summary – Key facts
• Subsidiary of Bayer AG
• Founded 1851 (Schering) merged in 2006
– 36,000 Employees, ~$14 billion Revenue (2009)
• One of the ten largest manufacturers for specialty
medicine
• World market leader in development of contrast media
for X-ray
Summary
Arne Stöcker
Denis Stoimenov Waldemar SeelJoachim Hacke Wan Mohd Norudin
Literature
• http://www.bayerhealthcare.com
• http://www.presse.bayer.de
• http://www.consumernewsweekly.com/
• http://www.bayerscheringpharma.de/en
• Bayer Schering Pharma Corporate Brochure May 2010
• Bayer AG Annual Report 2009
Arne Stöcker
Denis Stoimenov Waldemar SeelJoachim Hacke Wan Mohd Norudin
Thank you for your attention
Questions?!
Source: www.bayerscheringpharma.de